NCT06293885View on ClinicalTrials.gov

Pleurodesis Using Hypertonic Glucose

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Air Leak From Lung
Interventions
DRUG

Dextrose 50

a solution of 50% glucose (D50) will be injected into your pleural space

OTHER

Standard of Care - No Dextrose 50

Standard of Care

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER